Department of Pharmacy, Institute of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport (C_DAT), University of Greifswald, Felix-Hausdorff-Street 3, 17489, Greifswald, Germany.
Diurnal Limited, Cardiff Medicentre, Heath Park, Cardiff, CF14 4UJ, UK.
Pharm Res. 2020 Sep 24;37(10):203. doi: 10.1007/s11095-020-02912-x.
The objective of the present work was to screen whether a novel pediatric hydrocortisone granule formulation can be co-administered with common food matrices and liquids.
Pediatric hydrocortisone granules were studied using a biopredictive in vitro approach. Experiments included an in situ chemical compatibility study of active ingredient and drug product with liquid dosing vehicles and soft foods commonly ingested by infants, pre-school- and school children. Drug solubility and stability experiments in the different vehicle types and, drug release/dissolution experiments mimicking age-related pediatric gastric conditions after administering the hydrocortisone granules together with the dosing vehicles and after different exposure/mixing times were performed.
In the simulated dosing scenarios applied in dissolution experiments, in vitro dissolution in gastric conditions was rapid and complete. Results of the chemical compatibility/stability studies indicated that mixing with the different dosing vehicles studied should not be an issue regarding drug degradation products.
A novel in vitro approach ensuring a proper risk assessment of the use of dosing vehicles in the administration of pediatric dosage forms was established and applied to a novel pediatric hydrocortisone drug product. The studied dosing vehicles were shown to not alter performance of the drug product and are thus considered suitable for administration with hydrocortisone granules. Graphical abstract.
本研究旨在筛选新型儿科氢化可的松颗粒制剂是否可与常见食物基质和液体同时给药。
采用生物预测体外方法研究儿科氢化可的松颗粒。实验包括活性成分和药物产品与液体给药剂型以及婴幼儿、学龄前和学龄儿童常摄入的软食之间的原位化学相容性研究。在不同的载体类型中进行药物溶解度和稳定性实验,以及在给予氢化可的松颗粒和给药剂型后,模拟与年龄相关的儿科胃条件的药物释放/溶解实验,以及不同的暴露/混合时间。
在应用于溶解实验的模拟给药剂型中,胃条件下的体外溶解迅速且完全。化学相容性/稳定性研究的结果表明,与所研究的不同给药剂型混合不应导致药物降解产物出现问题。
建立了一种新的体外方法,可确保对儿科剂型给药中给药剂型的使用进行适当的风险评估,并将其应用于新型儿科氢化可的松药物产品。研究的给药剂型不会改变药物产品的性能,因此被认为适合与氢化可的松颗粒一起给药。